LUCAT1 and hepatocellular carcinoma: Upregulation of the oncogenic lncRNA LUCAT1 (also known as SCAL1) is found to be correlated with lower survival rates and poor clinical outcomes in lung, gastric, HCC, CRC, and RCC patients (Wu et al., 2020[57]; Xing et al., 2021[62]).